Global Single-Cell Analysis Market valued at USD 2.1 billion (2020), is growing at a healthy CAGR of 17.8% through the forecast period 2020-2025

Medi-Tech Insights offers an interesting research report on Global Single-Cell Analysis Market. The market growth is likely to be driven by emerging life science and oncology research.

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

List Bio Raises $48.4 Million Series A for Global Scale-Up

List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Scitara™ Digital Lab Exchange DLX™ Gains ISO Certification and Advances the Modern Lab with the Latest Release of its Barrier-Breaking Lab Integration Platform

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion through Digital Self-Service

Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and Scheduling Capabilities

Kyruus and Upfront Partner to Enable Healthcare Organizations to Maximize Digital Patient Acquisition and Retention

Partnership Offers Consumer-Centric Search and Scheduling Options While Closing Gaps in Care through Personalized Digital Outreach to Patients

Exogene raises $2 million for its AI platform to discover cell therapies for cancer

Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.

Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System

First-of-its-kind automated ultrasound platform now part of PerkinElmer portfolio aims to accelerate preclinical research

Abzena Opens a New Biologics Testing Lab to Support Partners Programs

Watson-Marlow Fluid Technology Solutions’ new name reflects strategy focused on delivering end-to-end fluid management solutions for customers

Watson-Marlow Fluid Technology Group - part of Spirax-Sarco Engineering plc, a FTSE 100 company - today announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth, the name change aligns with a strategic commitment to providing end-to-end fluid management solutions for customers.

BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Connectivity, Sustainability and User Experience to transform packaging and drug delivery in next year: Pharmapack Europe 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy products

Ripple Science and Curavit Clinical Research Sign Partnership Agreement to Accelerate Decentralized Clinical Trials (DCTs)

Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.